Jason Kreuziger

Jason Kreuziger, CFA, is a seasoned private equity investment professional currently serving as Managing Director at Goldman Sachs since July 2014, focusing on growth stage companies in the software, tech-enabled services, and healthcare IT sectors. In addition to this role, Kreuziger holds positions as Vice President and Board Member at 4G Clinical, contributing to the development of advanced trial management solutions for the life sciences industry. As a Board Member at TraceLink, Kreuziger supports efforts to enhance supply chain integrity in the pharmaceutical sector. Furthermore, Kreuziger is an angel investor in several innovative companies, including Rael, Oxeia Biopharmaceuticals, and ConnectHealth, which aim to improve healthcare and consumer products. With an MBA from Harvard Business School and a BBA in Finance and MIS from the University of Wisconsin-Madison, Kreuziger combines academic expertise with extensive professional experience to drive growth and innovation in various sectors.